PTCT · PTC Therapeutics
AI read · Good for PTCT
The AI's read
More patients are using Cephiance, and PTC says demand is growing in the U.S. and abroad. The sales trend supports growth, but cash-flow break-even remains an expectation, not a result already achieved.